XML Feed for RxPG News   Add RxPG News Headlines to My Yahoo!   Javascript Syndication for RxPG News

Research Health World General
 
  Home
 
 Latest Research
 Cancer
 Psychiatry
 Genetics
 Surgery
 Aging
 Ophthalmology
 Gynaecology
 Neurosciences
 Pharmacology
 Cardiology
 Obstetrics
 Infectious Diseases
 Respiratory Medicine
  Asthma
  COPD
  Cystic Fibrosis
 Pathology
 Endocrinology
 Immunology
 Nephrology
 Gastroenterology
 Biotechnology
 Radiology
 Dermatology
 Microbiology
 Haematology
 Dental
 ENT
 Environment
 Embryology
 Orthopedics
 Metabolism
 Anaethesia
 Paediatrics
 Public Health
 Urology
 Musculoskeletal
 Clinical Trials
 Physiology
 Biochemistry
 Cytology
 Traumatology
 Rheumatology
 
 Medical News
 Health
 Opinion
 Healthcare
 Professionals
 Launch
 Awards & Prizes
 
 Careers
 Medical
 Nursing
 Dental
 
 Special Topics
 Euthanasia
 Ethics
 Evolution
 Odd Medical News
 Feature
 
 World News
 Tsunami
 Epidemics
 Climate
 Business
Search

Last Updated: Nov 17th, 2006 - 22:35:04

Asthma Channel
subscribe to Asthma newsletter

Latest Research : Respiratory Medicine : Asthma

   DISCUSS   |   EMAIL   |   PRINT
Role for the A1 adenosine receptor in protecting against asthma
Jan 4, 2005, 19:35, Reviewed by: Dr.



 
Levels of the signaling molecule adenosine are increased in the lungs of asthmatics, and elevations of adenosine correlate with the degree of airway inflammation, suggesting that adenosine may play a provocative role in acute asthma attacks. Therefore much research has been focused on drugs that may potentially interact with known adenosine receptors the activation of which can have proinflammatory or anti-inflammatory effects, depending on the receptor type. Theophylline, the most widely prescribed drug for the treatment of airway disease worldwide, is able to block both pro- and anti-inflammatory actions of adenosine, potentially decreasing its efficiency. Researchers are now focused on determining the role of each adenosine receptor so that they may design drugs to interact with specific receptors and reduce airway inflammation.

As described in a report in the January 3 issue of the Journal of Clinical Investigation, Michael Blackburn led a team of researchers at the University of Texas Health Science Center and the National Institutes of Health to examine the role of the A1 adenosine receptor (A1AR) in a mouse model of lung injury and inflammation in which these mice possess elevated adenosine levels.

Blackburn et al. show that mice lacking A1AR die shortly after birth from severe inflammatory lung disease, indicating that A1AR serves an anti-inflammatory and thus protective role in the development of lung inflammation. The findings are particularly relevant in light of the fact that drugs that block A1AR are currently being investigated as a potential treatment for asthma.

In an accompanying commentary, Stephen Tilley and Richard Boucher from the University of North Carolina discuss this study and the potential clinical benefits of blocking A1 receptors in the airways of asthma patients.
 

- Journal of Clinical Investigation
 

A PDF of this article this article is available at: http://www.jci.org/cgi/content/full/115/1/35.

 
Subscribe to Asthma Newsletter
E-mail Address:

 

TITLE: A protective role for the A1 receptor in adenosine-dependent pulmonary injury

AUTHOR CONTACT: Michael R. Blackburn
Department of Biochemistry and Molecular Biology, University of Texas Health Science Center, Houston, Texas, USA.
Phone: 713-500-6087; Fax: 713-500-0652; E-mail: [email protected]



Related Asthma News

A dog in home may worsen asthma in children
PEAK Trial: Inhaled steroids do not prevent chronic asthma
Telithromycin antibiotic could help in asthma attack
Tomatoes, carrots can cut asthma risk
Inhaled steroid may work better for normal-weight people
Female foetus could increase expectant woman's asthma
Childhood Asthma Affecting More than Just Breathing
Omalizumab has long-term benefits in severe allergic asthma
CD23 structure revealed by NMR spectroscopy
Bacteria in Household Dust May Trigger Asthma


For any corrections of factual information, to contact the editors or to send any medical news or health news press releases, use feedback form

Top of Page

 

© Copyright 2004 onwards by RxPG Medical Solutions Private Limited
Contact Us